Help us: Donate
Follow us on:


Organization Description


Longeveron are a clinical-stage biotechnology company developing cellular therapies for age-related and life-threatening conditions. Their lead candidate product is Lomecel-B™, which is derived from medicinal signalling cells (MSCs), multipotent cells derived from mammalian bone marrow and periosteum that can be extended in culture. They believe that by using the same cells that promote tissue repair, organ maintenance, and immune system function, they can develop safe and effective therapies for some of the most difficult diseases and conditions associated with aging